Analogues of Arylamide Phenylpiperazine Ligands to Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity

Hamed S. Hayatshahi, Kuiying Xu, Suzy A. Griffin, Michelle Taylor, Robert H. Mach, Jin Liu, Robert T. Luedtke

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

We have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 versus the D2 dopamine receptor subtype. For these studies, we used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs D2 receptor binding selectivity. Our goal was to investigate how the composition and size of the nonaromatic ring structure at the piperazine position of substituted phenylpiperazine analogues might influence binding affinity at the human D2 and D3 dopamine receptors. Two factors were identified as being important for determining the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype. One factor was the strength of the salt bridge between the highly conserved residue Asp 3.32 with the protonated nitrogen of the nonaromatic ring at the piperazine position. The second factor was the configuration of the unbound ligand in an aqueous solution. These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands. While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.

Original languageEnglish
Pages (from-to)2972-2983
Number of pages12
JournalACS Chemical Neuroscience
Volume9
Issue number12
DOIs
StatePublished - 19 Dec 2018

Fingerprint

Dopamine D3 Receptors
Ligands
Dopamine D2 Receptors
Dopamine Receptors
Nitrogen
Salts
phenylpiperazine
Chemical analysis

Keywords

  • Bitropic ligands
  • D2-like dopamine receptors
  • D3 dopamine receptor subtype
  • G-protein coupled receptor (GPCR)
  • Umbrella sampling
  • docking
  • molecular dynamics
  • receptor subtype selective ligands

Cite this

@article{56c0a3269b5644f886c3b37e3cecade5,
title = "Analogues of Arylamide Phenylpiperazine Ligands to Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity",
abstract = "We have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 versus the D2 dopamine receptor subtype. For these studies, we used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs D2 receptor binding selectivity. Our goal was to investigate how the composition and size of the nonaromatic ring structure at the piperazine position of substituted phenylpiperazine analogues might influence binding affinity at the human D2 and D3 dopamine receptors. Two factors were identified as being important for determining the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype. One factor was the strength of the salt bridge between the highly conserved residue Asp 3.32 with the protonated nitrogen of the nonaromatic ring at the piperazine position. The second factor was the configuration of the unbound ligand in an aqueous solution. These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands. While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.",
keywords = "Bitropic ligands, D2-like dopamine receptors, D3 dopamine receptor subtype, G-protein coupled receptor (GPCR), Umbrella sampling, docking, molecular dynamics, receptor subtype selective ligands",
author = "Hayatshahi, {Hamed S.} and Kuiying Xu and Griffin, {Suzy A.} and Michelle Taylor and Mach, {Robert H.} and Jin Liu and Luedtke, {Robert T.}",
year = "2018",
month = "12",
day = "19",
doi = "10.1021/acschemneuro.8b00142",
language = "English",
volume = "9",
pages = "2972--2983",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "12",

}

Analogues of Arylamide Phenylpiperazine Ligands to Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity. / Hayatshahi, Hamed S.; Xu, Kuiying; Griffin, Suzy A.; Taylor, Michelle; Mach, Robert H.; Liu, Jin; Luedtke, Robert T.

In: ACS Chemical Neuroscience, Vol. 9, No. 12, 19.12.2018, p. 2972-2983.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Analogues of Arylamide Phenylpiperazine Ligands to Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity

AU - Hayatshahi, Hamed S.

AU - Xu, Kuiying

AU - Griffin, Suzy A.

AU - Taylor, Michelle

AU - Mach, Robert H.

AU - Liu, Jin

AU - Luedtke, Robert T.

PY - 2018/12/19

Y1 - 2018/12/19

N2 - We have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 versus the D2 dopamine receptor subtype. For these studies, we used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs D2 receptor binding selectivity. Our goal was to investigate how the composition and size of the nonaromatic ring structure at the piperazine position of substituted phenylpiperazine analogues might influence binding affinity at the human D2 and D3 dopamine receptors. Two factors were identified as being important for determining the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype. One factor was the strength of the salt bridge between the highly conserved residue Asp 3.32 with the protonated nitrogen of the nonaromatic ring at the piperazine position. The second factor was the configuration of the unbound ligand in an aqueous solution. These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands. While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.

AB - We have previously reported on the ability of arylamide phenylpiperazines to bind selectively to the D3 versus the D2 dopamine receptor subtype. For these studies, we used LS-3-134 as the prototypic arylamide phenylpiperazine ligand because it binds with high affinity at D3 dopamine receptor (0.17 nM) and exhibits >150-fold D3 vs D2 receptor binding selectivity. Our goal was to investigate how the composition and size of the nonaromatic ring structure at the piperazine position of substituted phenylpiperazine analogues might influence binding affinity at the human D2 and D3 dopamine receptors. Two factors were identified as being important for determining the binding affinity of bitropic arylamide phenylpiperazines at the dopamine D3 receptor subtype. One factor was the strength of the salt bridge between the highly conserved residue Asp 3.32 with the protonated nitrogen of the nonaromatic ring at the piperazine position. The second factor was the configuration of the unbound ligand in an aqueous solution. These two factors were found to be related to the logarithm of the affinities using a simple correlation model, which could be useful when designing high affinity subtype selective bitropic ligands. While this model is based upon the interaction of arylamide phenylpiperazines with the D2 and D3 D2-like dopamine receptor subtypes, it provides insights into the complexity of the factors that define a bitropic mode of the binding at GPCRs.

KW - Bitropic ligands

KW - D2-like dopamine receptors

KW - D3 dopamine receptor subtype

KW - G-protein coupled receptor (GPCR)

KW - Umbrella sampling

KW - docking

KW - molecular dynamics

KW - receptor subtype selective ligands

UR - http://www.scopus.com/inward/record.url?scp=85050245183&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00142

DO - 10.1021/acschemneuro.8b00142

M3 - Article

VL - 9

SP - 2972

EP - 2983

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 12

ER -